Clinical Trial Update: Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria [Phase 2]

View source ↗

Summary

A Phase IIa trial evaluating the efficacy and safety of SPP635 in hypertensive and type 2 diabetic patients with albuminuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• SPP635 (SPP635)

Snippet

Sponsor: Speedel Pharma Ltd. | Conditions: Hypertension, Type II Diabetes Mellitus | Phase 2 | Status: COMPLETED